AI Article Synopsis
- Obstructive sleep apnea (OSA) is becoming more common in the U.S., particularly among obese individuals, but there is a lack of data on sedation-related risks in undiagnosed OSA patients during procedures like EGD and colonoscopy.
- The study assessed 243 patients, finding a high prevalence (48.1%) of increased OSA risk (using the STOP-BANG questionnaire) without significantly higher rates of airway interventions (AI) or sedation-related adverse events (SRAE) compared to non-risk patients.
- Higher body mass index, age, greater propofol dosing, and smoking were linked to increased SRAE risk, indicating the need for careful monitoring of these factors in sedation practices.
Article Abstract
Background: Obstructive sleep apnea (OSA), which is linked to the prevalence of obesity, continues to rise in the United States. There are limited data on the risk for sedation-related adverse events (SRAE) in patients with undiagnosed OSA receiving propofol for routine EGD and colonoscopy.
Objective: To identify the prevalence of OSA by using the STOP-BANG questionnaire (SB) and subsequent risk factors for airway interventions (AI) and SRAE in patients undergoing elective EGD and colonoscopy.
Design: Prospective cohort study.
Setting: Tertiary-care teaching hospital.
Patients: A total of 243 patients undergoing routine EGD or colonoscopy at Cleveland Clinic.
Intervention: Chin lift, mask ventilation, placement of nasopharyngeal airway, bag mask ventilation, unplanned endotracheal intubation, hypoxia, hypotension, or early procedure termination.
Main Outcome Measurements: Rates of AI and SRAE.
Results: Mean age of the cohort was 50 ± 16.2 years, and 41% were male. The prevalence of SB+ was 48.1%. The rates of hypoxia (11.2% vs 16.9%; P = .20) and hypotension (10.4% vs 5.9%; P = .21) were similar between SB- and SB+ patients. An SB score ≥3 was found not to be associated with occurrence of AI (relative risk [RR] 1.07, 95% confidence interval [CI] 0.79-1.5) or SRAE (RR 0.81, 95% CI, 0.53-1.2) after we adjusted for total and loading dose of propofol, body mass index (BMI), smoking, and age. Higher BMI was associated with an increased risk for AI (RR 1.02; 95% CI, 1.01-1.04) and SRAE (RR 1.03; 95% CI, 1.01-1.05). Increased patient age (RR 1.09; 95% CI, 1.02-1.2), higher loading propofol doses (RR 1.4; 95% CI, 1.1-1.8), and smoking (RR 1.9; 95% CI, 1.3-2.9) were associated with higher rates of SRAE.
Limitations: Non-randomized study.
Conclusion: A significant number of patients undergoing routine EGD and colonoscopy are at risk for OSA. SB+ patients are not at higher risk for AI or SRAE. However, other risk factors for AI and SRAE have been identified and must be taken into account to optimize patient safety.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gie.2013.09.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!